ArticleCureus2025
Bilateral Central Serous Chorioretinopathy Associated With Tuberculosis in a Female Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a novel case of central serous chorioretinopathy (CSCR) associated with tuberculosis in a female patient. A 29-year-old female was referred with bilateral atypical CSCR following steroid treatment for suspected optic neuritis. Examination showed bilateral hypermetropic shift and foveal subretinal fluid (SRF). Optical coherence tomography (OCT) confirmed bilateral serous retinal detachment, with associated pigment epithelial detachments in the right eye. A raised erythrocyte sedimentation rate prompted multidisciplinary investigation, eliciting radiological and serological findings consistent with latent pulmonary tuberculosis. Follow-up four days following commencing anti-tuberculosis treatment showed reduction of SRF bilaterally. Complete resolution and return to visual baseline was observed at three months. Prompt CSCR resolution might have been secondary to rifampicin inducing steroid metabolism or effective anti-tuberculosis treatment. Early investigation for tuberculosis in CSCR may enable earlier diagnosis, improving visual outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.